Phathom Pharmaceuticals
PHAT
PHAT
110 hedge funds and large institutions have $453M invested in Phathom Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.11% less ownership
Funds ownership: 78.15% → 77.04% (-1.1%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
26% less capital invested
Capital invested by funds: $613M → $453M (-$160M)
Holders
110
Holding in Top 10
4
Calls
$1.61M
Puts
$326K
Top Buyers
| 1 | +$4.51M | |
| 2 | +$2.68M | |
| 3 | +$2.59M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.5M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.18M |
Top Sellers
| 1 | -$9.39M | |
| 2 | -$3.58M | |
| 3 | -$3.45M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.86M |
| 5 |
6CM
683 Capital Management
New York
|
-$1.94M |